SCHEMBL4319841

SCHEMBL4319841

Nc1cccc2c1C(=O)N(c1ccccc1/C=C/c1n[nH]c3ccccc13)C2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H3 Q13133 10/20 0.43
▸ NR1H2 P55055 8/20 0.43
▸ HSPA1A P0DMV8 1/20 0.42
▸ PABPC1 P11940 1/20 0.42
▸ DPP4 P27487 1/20 0.38
▸ ADORA2A P29274 1/20 0.38
▸ POLB P06746 1/20 0.36
▸ BMPR1B O00238 1/20 0.36
▸ PLK4 O00444 1/20 0.36
▸ STK25 O00506 1/20 0.36
▸ CIT O14578 1/20 0.36
▸ RIOK3 O14730 1/20 0.36
▸ CHEK1 O14757 1/20 0.36
▸ IKBKB O14920 1/20 0.36
▸ AURKA O14965 1/20 0.36
▸ GAK O14976 1/20 0.36
▸ DCLK1 O15075 1/20 0.36
▸ CHUK O15111 1/20 0.36
▸ MUSK O15146 1/20 0.36
▸ EPHB6 O15197 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4319846 1.00 NR1H3 (0.43) NR1H3NR1H2HSPA1APABPC1DPP4
SCHEMBL4327508 0.89 NR1H3 (0.53) NR1H3NR1H2POLBBMPR1BPLK4
SCHEMBL4327512 0.89 NR1H3 (0.53) NR1H3NR1H2POLBBMPR1BPLK4
SCHEMBL4311428 0.88 ALPL (0.45) NR1H3NR1H2CHEK1CDK4
SCHEMBL4321223 0.88 NR1H3 (0.42) NR1H3NR1H2DPP4POLBBMPR1B
SCHEMBL4311434 0.88 ALPL (0.45) NR1H3NR1H2CHEK1CDK4
SCHEMBL4321216 0.88 NR1H3 (0.42) NR1H3NR1H2DPP4POLBBMPR1B
SCHEMBL4308926 0.88 KDM4E (0.38) NR1H3HSPA1APABPC1DPP4ADORA2A
SCHEMBL4308931 0.88 KDM4E (0.38) NR1H3HSPA1APABPC1DPP4ADORA2A
SCHEMBL4310272 0.86 KDR (0.38) NR1H3HSPA1APABPC1DPP4ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 — — US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 — — US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 NR1H3 667/4885NR1H2 481/4885HSPA1A 2565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback